Ardent HealthARDT
Recorded

Ardent Health M&A announcement

Review the key takeaways and the transcript of this earnings call.

Period 0Duration39 minParticipants11

Transcript

Preview the first fifteen paragraphs, organized by speaker.

Operator

I will now hand the conference over to Dave Styblo, Senior Vice President of Investor Relations.

Dave StybloSVP of Investor Relations

Dave, please go ahead. Thank you, operator, and welcome to our conference call to discuss Ardent Health's acquisition of the Boone Health System.

Dave StybloSVP of Investor Relations

Joining me today is Ardent President and Chief Executive Officer, Dave Caspers, and Chief Financial Officer, Alfred Lumsdaine. Dave and Alfred will provide prepared remarks, and then we will open the line to questions. Additionally, we would encourage participants to view an investor presentation we have posted to the Investor Relations section of our company website that can be used in conjunction with today's call. I want to remind everyone that today's discussion contains forward-looking statements about future business and financial expectations. Actual results may differ significantly from those projected in today's forward-looking statements due to various risks and uncertainties, including the risks described in our periodic reports filed with the Securities and Exchange Commission and the risks identified in the press release announcing the Boone Health transaction.

Dave StybloSVP of Investor Relations

Except as required by law, we undertake no obligation to update our forward-looking statements. Further, this call will include the discussion of certain non-GAAP financial measures, including Adjusted EBITDA. Reconciliation of these measures to the closest GAAP financial measures is included in the investor presentation for this call and available at ardenthealth.com. With that, I'll turn the call over to Dave.

Dave CaspersPresident and CEO

Good evening, and thank you for joining us. Today marks an exciting milestone for Ardent as we announce a $47 million definitive agreement to acquire Boone Health System, a highly respected and integrated regional health system that has served the mid-Missouri area for more than a century. This transaction is a direct reflection of Ardent's growth strategy. As we have consistently discussed with investors, our approach to shareholder value creation rests on three pillars: operational excellence to strengthen margins, organic growth in our core markets, and strategic capital deployment, including disciplined M&A. Boone advances that third pillar in a significant way and is exactly the type of acquisition we seek. We are acquiring a strong asset in an attractive and growing mid-sized market with significant opportunity to drive operating and financial improvement, all while delivering high patient quality care and safety.

Dave CaspersPresident and CEO

It also represents an effective use of capital at a compelling valuation that we expect will create long-term shareholder value. I will cover each of these investment highlights during the rest of my prepared remarks. Boone is a high-performing organization with a trusted brand, an experienced leadership team, and deep community roots. The health system generates nearly $500 million of revenue and is anchored by its 392-bed full-service tertiary hospital in Columbia, Missouri, that serves as a referral hub for 26 counties in the mid-state. Their integrated system consists of 19 sites of care, including an outpatient campus of five medical office buildings to care for the community. The facilities are modern and well-maintained and include a main bed tower that was built in 2011. Consequently, maintenance capital needs are relatively low, and we can direct investment towards growth initiatives.

Dave CaspersPresident and CEO

Boone is the second-largest provider in the region and holds a strong market share of approximately 30%. Boone has established strong positions in cardiovascular services, orthopedics, women's services, oncology, and other specialties. Its quality credentials are distinctive. The health system has earned recognition for clinical quality, patient experience, and nursing excellence. Its four-star CMS rating is highest in the region, and strong performance in other key categories, including readmission rates and HCAHPS. They lead the peers. The local market profile is attractive. The region offers favorable demographics, strong population growth, and high employment. Specifically, Columbia, Missouri's population is expected to increase 3.4% over the next five years, faster than the national average of 2%. Additionally, the market is well-insured, with 93% of the population enrolled in coverage. Now, let us turn to the strategic rationale for the transaction, which we find extremely compelling.

Dave CaspersPresident and CEO

Boone expands our footprint into a new attractive market. It diversifies our business and enhances scale. Further adding Boone's regional system to our portfolio is consistent with our strategy of building leading healthcare platforms in growing mid-sized communities. We are highly aligned with Boone Health on culture and mission, including putting the patient at the center of everything we do with an aim toward best-in-class clinical care, patient quality, safety, and access to services. That care is delivered by a strong provider team that we hold in high regard. In short, Boone fits exceptionally well with Ardent's operating model. Importantly, we see meaningful opportunities to optimize financial performance. This includes multiple pathways for margin expansion by leveraging Ardent's scale, platform, and our operational excellence.

Dave CaspersPresident and CEO

We have identified at least $30 million of annual synergies that we expect to fully realize in year three and project the year three Adjusted EBITDA contribution will be between $30 million and $40 million. Additionally, we see upside to that synergy target from opportunities to enhance financial performance and access to care through capital investments that strengthen service lines and increase market share. As an example, near-term initial investments consist of expanding emergency department capacity to better meet the existing demand. Lastly, this transaction is a disciplined and effective use of capital. We have established detailed integration plans and quantified savings for specific work streams, each anchored by key milestones and clear accountability. Executing against these initiatives should generate an attractive ROI. Ultimately, we expect the purchase price to be less than two times our expected year three Adjusted EBITDA and accretive to our shareholder value.

Dave CaspersPresident and CEO

Equally important, this combination brings significant benefits for the communities that Boone served by leveraging Ardent's capital, scale, and operating excellence. We are committing $200 million of capital over the next decade, which signals our commitment to accelerate investments in the health system. This will support service line expansion, technology upgrades, and physician recruitment. The investments will help improve patient access, support caregivers, and ensure the community can continue receiving advanced care close to home. Additionally, Boone benefits from Ardent's system-wide clinical and quality programs, technology and IT infrastructures, and operational excellence that help strengthen care delivery. At the same time, Boone's local identity and patient-centered culture are fully maintained. Our philosophy is simple. When we partner with community health systems, we build on their existing strengths while bringing the tools, resources, and operating expertise needed to support sustainable growth and long-term performance.

Dave CaspersPresident and CEO

We are committed to advancing Boone's mission, supporting local leadership, continuing the charity care programs, and establishing a local advisory board to maintain the very strong community involvement. We believe this partnership positions both Boone and Ardent for long-term success. Before I turn the call over to Alfred to discuss the transaction terms and financial benefits, I want to step back and highlight the Boone acquisition comes on the heels of our September announcement to divest our Kansas hospital. Together, these strategic decisions reflect our commitment to sharpen focus, to improve margins, and to optimize capital allocation. Whether we're pruning with intention, as in the case of Kansas, or deploying capital through disciplined M&A, as with Boone, the objective is the same: maximize shareholder value as we curate the portfolio. With that, I'll turn it over to Alfred.

Alfred LumsdaineCFO

Thank you, Dave. Good evening, everyone. I share Dave's excitement for bringing together the strengths and capabilities of both organizations to build on Boone's strong foundation. Collectively, we can further enhance care delivery as well as optimize operating and financial performance. From a financial perspective, this transaction reflects the disciplined capital allocation framework we consistently communicate to investors. We evaluate opportunities through a straightforward lens: strategic fit, financial return, execution risk, and long-term shareholder value creation. Boone scores exceptionally well across each of these dimensions. Under the terms of the agreement, Ardent will acquire Boone Health for a purchase price of approximately $47 million, subject to customary working capital and closing adjustments. The acquisition will be funded entirely with existing cash, demonstrating the strength and flexibility of our strong balance sheet. Boone will use the proceeds to retire all of its outstanding debt and satisfy other retained obligations.

Alfred LumsdaineCFO

Thus, Ardent will be inheriting a debt-free asset when the transaction closes. Additionally, we will fully own all associated real estate, which further strengthens our balance sheet. As Dave mentioned, we're committing to invest $200 million of capital over 10 years to support Boone's strategic growth initiatives. This equates to approximately 3%-4% of revenue over that time, which is consistent with our current standalone capital spending. Said differently, the $200 million commitment should be viewed as ongoing stewardship of the asset, not an incremental investment on top of the $47 million purchase price. Importantly, this transaction has a de minimis impact on our lease-adjusted net leverage profile. This allows us to maintain our strong balance sheet and capital deployment flexibility. Last, we expect to close the acquisition in the first quarter of 2027, subject to customary closing conditions.

Alfred LumsdaineCFO

From a shareholder perspective, we believe this acquisition represents a strong value creation opportunity. Our team has spent the last 12 months performing a full assessment of the value-enhancing activities and creating a detailed action plan for the Boone system. We have identified and quantified savings initiatives tied to specific projects and work streams, complete with timelines and specific ownership. That playbook builds to our expectation that we will achieve at least $30 million of synergies in year three. The savings will begin in year one and ramp over time. Importantly, we have high confidence in executing our plans to realize this target. The synergies are primarily driven by cost efficiencies that leverage Ardent's scale, purchasing power, and operational strengths. We will capture them through proven integration levers, including supply chain procurement, revenue cycle optimization, vendor consolidation, and general administrative costs. Overall, the transaction strengthens and accelerates Ardent's earnings growth playbook.

Alfred LumsdaineCFO

We project Boone will generate $30 million-$40 million of Adjusted EBITDA in year three. In terms of cadence, we expect that in year one, the acquisition will be modestly accretive to our current 2026 Adjusted EBITDA guidance midpoint, ramping to 6%-8% accretion in year three. Looking further out, we see continued opportunity to enhance performance. The expected year three Adjusted EBITDA margin of 6%-7% shouldn't be viewed as the ceiling. We have plenty of room to advance profitability closer to our corporate average in the longer term. Tying this together from an investment standpoint, the $47 million purchase price represents a multiple of less than 2x our projected year three Adjusted EBITDA. We view this as a disciplined value-creating use of capital with a very attractive risk-reward profile.

FULL TRANSCRIPT

Continue the full translated transcript in StockNow.

Access every statement, the English original, and speaker-by-speaker history with StockNow Pro.

View the full transcript with Pro

Other earnings calls that day

View calls from this day